NAI FOVINO, LUCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.006
AS - Asia 1.572
EU - Europa 1.296
SA - Sud America 420
AF - Africa 338
OC - Oceania 36
Continente sconosciuto - Info sul continente non disponibili 12
Totale 6.680
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.835
SG - Singapore 485
IT - Italia 408
CN - Cina 354
BR - Brasile 308
HK - Hong Kong 296
DE - Germania 142
PL - Polonia 100
FI - Finlandia 79
SE - Svezia 68
RU - Federazione Russa 64
VN - Vietnam 60
KR - Corea 56
FR - Francia 54
GB - Regno Unito 52
NL - Olanda 49
IE - Irlanda 28
IN - India 24
AR - Argentina 22
AT - Austria 22
CI - Costa d'Avorio 21
JP - Giappone 20
CA - Canada 19
UA - Ucraina 19
MA - Marocco 18
SO - Somalia 18
TR - Turchia 18
MX - Messico 16
ZA - Sudafrica 16
ES - Italia 15
IQ - Iraq 15
MN - Mongolia 15
PE - Perù 15
PY - Paraguay 15
TW - Taiwan 15
AU - Australia 13
CM - Camerun 13
CV - Capo Verde 13
CO - Colombia 12
EC - Ecuador 12
EG - Egitto 12
GR - Grecia 12
KE - Kenya 12
UZ - Uzbekistan 12
AE - Emirati Arabi Uniti 11
AL - Albania 11
BE - Belgio 11
CL - Cile 11
CR - Costa Rica 11
IS - Islanda 11
JM - Giamaica 11
PA - Panama 11
AO - Angola 10
IL - Israele 10
MD - Moldavia 10
MY - Malesia 10
MZ - Mozambico 10
NP - Nepal 10
PH - Filippine 10
YT - Mayotte 10
AM - Armenia 9
AZ - Azerbaigian 9
BD - Bangladesh 9
CH - Svizzera 9
DK - Danimarca 9
DO - Repubblica Dominicana 9
DZ - Algeria 9
ET - Etiopia 9
GA - Gabon 9
GN - Guinea 9
HN - Honduras 9
HU - Ungheria 9
ID - Indonesia 9
KG - Kirghizistan 9
KZ - Kazakistan 9
LC - Santa Lucia 9
MU - Mauritius 9
NI - Nicaragua 9
NO - Norvegia 9
PT - Portogallo 9
RS - Serbia 9
RW - Ruanda 9
TH - Thailandia 9
TJ - Tagikistan 9
BJ - Benin 8
BY - Bielorussia 8
CZ - Repubblica Ceca 8
IR - Iran 8
JO - Giordania 8
ME - Montenegro 8
MG - Madagascar 8
MW - Malawi 8
NZ - Nuova Zelanda 8
PR - Porto Rico 8
VE - Venezuela 8
XK - ???statistics.table.value.countryCode.XK??? 8
AF - Afghanistan, Repubblica islamica di 7
BA - Bosnia-Erzegovina 7
BB - Barbados 7
BZ - Belize 7
Totale 6.380
Salva come PNG Salva come JPEG
Città #
Fairfield 390
Ashburn 328
Singapore 313
Hong Kong 284
Chandler 234
Cambridge 195
Woodbridge 187
Seattle 152
Beijing 136
Houston 130
Wilmington 116
Santa Clara 110
Ann Arbor 108
Padova 91
Bytom 85
Boardman 76
Munich 64
Hefei 51
Medford 50
Princeton 47
Seoul 47
Milan 43
San Diego 43
Helsinki 40
Turku 32
Des Moines 30
Buffalo 28
São Paulo 28
Los Angeles 26
Abidjan 21
Dublin 21
London 20
Ho Chi Minh City 17
Nanjing 15
Nuremberg 15
Ulan Bator 15
Chicago 14
Rome 14
Dong Ket 13
Praia 12
Tashkent 12
Vienna 12
Brasília 11
Falkenstein 11
Hanoi 11
Palermo 11
Hargeisa 10
Jinan 10
Lima 10
Panama City 10
Rheinfelden 10
Baku 9
Castries 9
Conakry 9
Dushanbe 9
Istanbul 9
Kigali 9
Libreville 9
Luanda 9
Managua 9
New York 9
Ogden 9
Rio de Janeiro 9
San José 9
Tokyo 9
Amman 8
Boston 8
Brooklyn 8
Cairo 8
Johannesburg 8
Maputo 8
Nairobi 8
Yerevan 8
Accra 7
Asunción 7
Baghdad 7
Belo Horizonte 7
Bishkek 7
Bridgetown 7
Charlotte 7
Cotonou 7
Douala 7
Kingston 7
Kuala Lumpur 7
Niamey 7
Podgorica 7
Reykjavik 7
Roxbury 7
Stockholm 7
Warsaw 7
Washington 7
Addis Ababa 6
Amsterdam 6
Athens 6
Bangkok 6
Belgrade 6
Cagliari 6
Cayenne 6
Djibouti 6
George Town 6
Totale 4.129
Salva come PNG Salva come JPEG
Nome #
Real-World Experience With a Large Bore Vascular Closure Device During TAVI Procedure: Features and Predictors of Access-Site Vascular Complications 176
'Full-plastic jacket' with bioresorbable vascular scaffolds: 5-year optical coherence tomography follow-up 173
Asymptomatic Severe Aortic Stenosis and Noncardiac Surgery 167
Anatomical Predictors of Pacemaker Dependency after Transcatheter Aortic Valve Replacement 167
A2-P3 oblique clipping for the treatment of severe mitral regurgitation in the presence of mitral valve cleft and flail 152
TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary? 144
“Full-plastic jacket” with everolimus-eluting Absorb bioresorbable vascular scaffolds: Clinical outcomes in the multicenter prospective RAI registry (ClinicalTrials.gov Identifier: NCT02298413) 138
Transcatheter aortic valve replacement for bicuspid aortic valve stenosis with first- and new-generation bioprostheses: A systematic review and meta-analysis 137
Unmasking Myocardial Bridge-Related Ischemia by Intracoronary Functional Evaluation 132
Coronary angiography after transcatheter aortic valve replacement (TAVR) to evaluate the risk of coronary access impairment after tavr-in-tavr 132
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 131
[Impact of COVID-19 pandemic on structural heart interventions in Italy] 127
Optimal duration of dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes: The SECURITY (Second-Generation Drug-Eluting Stent Implantation Followed by Six- Versus Twelve-Month Dual Antiplatelet Therapy)-diabetes substudy 123
Definition of trAnscatheter heart Valve orIeNtation in biCuspId aortic valve: The DA VINCI pilot study 122
Using wearable devices to monitor physical activity in patients undergoing aortic valve replacement: Protocol for a prospective observational study 121
Non-culprit coronary vasospasm in a woman affected by Churg-Strauss syndrome presenting with ST-elevation myocardial infarction 120
Long-term outcomes and prosthesis performance after transcatheter aortic valve replacement: Results of self-expandable and balloon-expandable transcatheter heart valves 118
The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: A systematic review and meta-analysis 117
Coronary access after transcatheter aortic valve replacement 117
Factors influencing the choice between transcatheter and surgical treatment of severe aortic stenosis in patients younger than 80 years: Results from the OBSERVANT study 116
Coronary Access and Percutaneous Coronary Intervention up to 3 Years after Transcatheter Aortic Valve Implantation with a Balloon-Expandable Valve 114
Transcatheter aortic valve implantation in lower-risk patients: what is the perspective? 113
Timing of Oral P2Y12 Inhibitor Administration in Non-ST Elevation Acute Coronary Syndrome 113
Incidence and feasibility of coronary access after transcatheter aortic valve replacement 111
The interplay between permanent pacemaker implantation and mortality in patients treated by transcatheter aortic valve implantation: A systematic review and meta-analysis 110
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trials 109
Coronary Access After Transcatheter Aortic Valve Replacement With Commissural Alignment: The ALIGN-ACCESS Study 108
Coronary Access After Transcatheter Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Lights and Shades 106
Transcatheter treatment of native aortic valve regurgitation: Results from an international registry using the transfemoral ACURATE neo valve 102
Pulmonary artery rupture during right heart catheterization: Successful endovascular treatment with Amplatzer Vascular Plug 99
Transcatheter versus surgical aortic valve replacement in low- and intermediate-risk patients: an updated systematic review and meta-analysis 95
Lifetime Strategy of Patients With Aortic Stenosis: The First Cut Is the Deepest 95
10-Year Impact of Transcatheter Aortic Valve Replacement Leaflet Design (Intra- Versus Supra-Annular) in Mortality and Hemodynamic Performance 94
Percutaneous repair of ascending aorta pseudoaneurysm and aortopulmonary fistula with two Amplatzer septal occluder devices 93
Tavr-in-tavr and coronary access: Importance of preprocedural planning 92
[Prosthesis embolization during transcatheter aortic valve implantation] 91
Transcatheter Aortic Valve Replacement With Self-Expanding ACURATE neo2: Postprocedural Hemodynamic and Short-Term Clinical Outcomes 90
A large, prospective, multicentre study of left main PCI using a latest-generation zotarolimus-eluting stent: the ROLEX study 90
[Left main percutaneous coronary intervention using zotarolimus-eluting stent: data from the ROLEX registry] 89
High-risk percutaneous coronary intervention using hemodynamic support device eight years after transcatheter aortic valve implantation 89
Transfemoral aortic valve implantation with new-generation devices: The repositionable Lotus vs. The balloon-expandable Edwards Sapien 3 valve 88
Institutional re-evolution of mitral valve procedures 87
Coronary Access and TAVR-in-TAVR: Don't Put Off Until Tomorrow What You Can Do Today 86
Left ventricular outflow tract rupture during transcatheter aortic valve implantation: anatomic evidence of the vulnerable area 84
Transcatheter aortic valve-in-valve implantation for the treatment of a failed surgical bioprosthesis of small size 83
Left main bifurcation PCI with the culotte technique using two self-apposing stents 82
Prevalence and Prognostic Impact of Carotid Artery Disease in Patients Undergoing TAVI 82
Treatment of aortic stenosis in patients with chronic liver disease: Another win for transfemoral TAVR? 81
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves 80
The rescue snared wire technique for challenging transcatheter pulmonary valve implantation: A case series of two patients 76
Preexisting diastolic dysfunction in patients undergoing TAVR matters—But what about diastole the day after TAVR? 75
Transcatheter aortic valve replacement for structural degeneration of previously implanted transcatheter valves (TAVR-in-TAVR): a systematic review 73
Transcatheter Aortic Valve Replacement in Failed Transcatheter Bioprosthetic Valves 73
Association between surgical risk and 30-day stroke after transcatheter versus surgical aortic valve replacement: a systematic review and meta-analysis 70
TAVR versus SAVR in patients with severe aortic stenosis and concomitant end stage liver disease: When less is more 70
Management and Outcome of Acute Ischemic Stroke Complicating Transcatheter Aortic Valve Replacement 67
Anatomical and pathophysiological considerations on the left main coronary artery 66
Impact of a 10 Rules Protocol on COVID-19 Hospital-Related Transmission: Insights from Padua University Hospital, Italy 66
Subclinical coronary artery disease in COVID-19 patients 65
Reducing vascular complications of large-bore sheaths removal with a novel post-closure technique: Adapt and evolve 65
Timing of Oral P2Y12 Inhibitor Administration in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome 64
Negative impact of coronavirus on interventional cardiology fellows' training: Let's limit collateral damage of the pandemic 63
Treatment of degenerated surgical aortic valve: The importance of having a "lifetime strategy" in younger patients with severe aortic disease 62
New-Onset Exertional Dyspnea in a Young Patient With Previous Blunt Chest Trauma 59
Diagnostic and prognostic value of gated myocardial perfusion single-photon emission computed tomography in low-risk patients with left bundle-branch block 55
Coronary Access and Percutaneous Coronary Intervention Up to 3 Years After Transcatheter Aortic Valve Implantation With a Balloon-Expandable Valve 49
Management of coronary artery disease in patients undergoing transcatheter aortic valve implantation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions in collaboration with the ESC Working Group on Cardiovascular Surgery 47
Diagnostic and Prognostic meaning of Gated Stress Cardiac Single-Photon Emission Computed Tomography Imaging (gated SPECT) in patients with Left Bundle-Brunch Block (LBBB) and without Coronary Artery Disease (CAD). 46
Risk stratification and prognostic assessment by gated Single Photon Emission Computed Tomography (SPECT) in patients with Left Bundle-Branch Block (LBBB). 43
Risk Stratification and Prognostic Assessment by Myocardial Perfusion gated single photon emission computed tomography (SPECT) in Patients with Left Bundle-Branch Block (LBBB) and Low-Intermediate Cardiac Risk 40
Prognostic value of myocardial perfusion scintigraphy in elderly patients with hypertension: a 10-year follow-up analysis 36
Impella ventricular assist device: A "valvular bypass" to support high-risk percutaneous coronary intervention or complicated transcatheter aortic valve replacement 34
DinoSAVR struck by the TAVR asteroids 1
Totale 6.851
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.054
article - articoli 25.786
book - libri 337
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.177
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021566 0 0 61 61 83 53 25 55 75 46 62 45
2021/2022694 15 58 57 44 44 70 17 70 112 25 39 143
2022/2023731 94 35 26 73 78 53 10 29 44 20 34 235
2023/2024520 15 65 47 31 46 38 49 35 61 34 53 46
2024/20251.884 12 139 76 51 193 80 91 178 148 117 320 479
2025/20261.813 411 537 865 0 0 0 0 0 0 0 0 0
Totale 6.851